Achievable but aggressive from a cost standpoint
By acting on melanocortin receptors in the central nervous system, it can suppress appetite and increase lipid mobilization
This makes it potentially suitable for individuals with insulin resistance, pre-diabetes, or type 2 diabetes, populations who would not be good candidates for growth hormone therapy due to its glucose-elevating effects
In other words, a high test result may reflect recent intake rather than a medical problem
METAOD003: A Phase IIa (double-blind, placebo-controlled 4 4 Latin Square design) safety study with single doses (9, 27 and 54 mg AOD9604) administered orally (capsules) to 17 healthy, clinically obese males presenting with a BMI 35 kg/m 2
Compound Specifications Why Research Laboratories Select 5-Amino-1MQ 5-Amino-1MQ is the most widely referenced selective NNMT inhibitor in current enzyme biology and methylation pathway research